Intelliseq provides a cloud-based platform for automated analysis and clinical interpretation of Next Generation Sequencing (NGS) genetic data, enabling users to generate actionable insights without requiring bioinformatics expertise. The platform addresses the need for efficient and accurate genomic diagnostics by offering customizable workflows for various medical applications, including diagnostics, therapy, and prevention.
Funding
$4.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Analyzing and interpreting Next Generation Sequencing (NGS) data to derive clinical insights is complex, often requiring specialized bioinformatics expertise and significant manual effort. This complexity creates a bottleneck in genomic diagnostics, hindering the efficient application of NGS data in clinical settings for diagnostics, therapy, and prevention.
Solution
Intelliseq offers a cloud-based platform, iFlow, designed to automate the analysis and clinical interpretation of NGS genetic data, enabling users to generate actionable insights without requiring extensive bioinformatics skills. The platform provides customizable, ready-to-use workflows tailored for various medical applications, including diagnostics, therapy selection, and preventative care. By automating the NGS data reporting process, iFlow allows users to perform thousands of analyses simultaneously, scaling interpretation capabilities while ensuring data safety and quality through compliance with industry regulations such as ISO13485, HIPAA, GDPR, and IEEE 2791-2020 (BCO). The platform's intuitive interface simplifies the analysis process, making it accessible to users without specialized bioinformatics training, and can be used as a standalone solution or a plug-in to existing Laboratory Information Management Systems (LIMS).
Target Audience
The primary target audience includes medical professionals, researchers, and healthcare organizations seeking to streamline NGS data analysis and interpretation for diagnostics, therapy, and prevention.
Features
- Fully automated end-to-end pipelines for raw genetic data analysis, including GeneSpect Hereditary, Somatic, PGx (Pharmacogenomics), and PRS (Polygenic Risk Score) Reporters.
- Customica builder allows users to fully control how data is analyzed and reported.
- Compliant with industry regulations: ISO13485, HIPAA, GDPR, IEEE 2791-2020 (BCO).
- Automated variant pathogenicity assessment and clinical insight report generation.
- Integration capabilities with existing LIMS systems.
- Cloud-based platform eliminates the need for high-power computing facilities and upfront installation costs.